InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,965.18
(
-0.34%
)
US TECH 100
20,437.60
(
-0.26%
)
Dow Jones
43,788.41
(
-0.39%
)
Brent Oil
71.97
(
0.15%
)
Bitcoin
89,249.32
(
-1.46%
)
Post# of 253596
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120722
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biopearl post# 136343

Thursday, 02/02/2012 9:20:48 PM

Thursday, February 02, 2012 9:20:48 PM

Post# of 253596

Possibly but maybe not if they come equipped with an "antidote" that is relatively cheap and readily available.

None of these drugs (Pradaxa, Eliquis, Xarelto) has a known antidote.

Since basic mechanisms of action may be different also it is hard to speculate what the bleeding risk during procedures might be until we get more experience.

Eliquis and Xarelto have exactly the same MoA: inhibiting Factor Xa. Pradaxa is different: it inhibits Factor IIa (thrombin).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up